Zoledronic acid prevents decreases in bone mineral density in patients with prostate cancer undergoing combined androgen blockade.
about
Zoledronic acid prevents decreases in bone mineral density in patients with prostate cancer undergoing combined androgen blockade.
description
2014 nî lūn-bûn
@nan
2014 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Zoledronic acid prevents decre ...... ng combined androgen blockade.
@ast
Zoledronic acid prevents decre ...... ng combined androgen blockade.
@en
Zoledronic acid prevents decre ...... ng combined androgen blockade.
@nl
type
label
Zoledronic acid prevents decre ...... ng combined androgen blockade.
@ast
Zoledronic acid prevents decre ...... ng combined androgen blockade.
@en
Zoledronic acid prevents decre ...... ng combined androgen blockade.
@nl
prefLabel
Zoledronic acid prevents decre ...... ng combined androgen blockade.
@ast
Zoledronic acid prevents decre ...... ng combined androgen blockade.
@en
Zoledronic acid prevents decre ...... ng combined androgen blockade.
@nl
P2093
P2860
P356
P1433
P1476
Zoledronic acid prevents decre ...... ng combined androgen blockade.
@en
P2093
Akinori Iba
Kazuro Kikkawa
Nagahide Matsumura
Satoshi Nishizawa
Takeshi Inagaki
Yasuo Kohjimoto
Yoshiki Kodama
P2860
P2888
P356
10.1186/2193-1801-3-586
P577
2014-10-08T00:00:00Z
P5875
P6179
1023620427